andromeda study: updated safety run-in results
Published 3 years ago • 217 plays • Length 1:21Download video MP4
Download video MP3
Similar videos
-
2:00
andromeda trial: d-vcd versus vcd in the treatment of patients with newly diagnosed al amyloidosis
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
2:00
update of a phase i trial investigating lintuzumab-ac225 plus venetoclax in r/r aml
-
1:55
phase i/ib safety study of prgn-3006 ultracar-t in patients with r/r cd33-positive aml & hr-mds
-
6:24
indiko biochemistry analyzer demonstration
-
1:46:07
hematology lecture
-
19:06
peripheral blood smear: examination of rbc
-
4:13
real-world study determining the safety and efficacy of teclistamab in r/r multiple myeloma
-
1:55
safety and efficacy of nxc-201, an anti-bcma car-t, in r/r al amyloidosis
-
5:07
daratumumab in the management of al amyloidosis
-
1:03
updated results of hyper-cvad and blinatumomab /- inotuzumab ozogamicin in newly-diagnosed b-all
-
5:51
safety of hbi0101 (nxc-201), a novel academic anti-bcma car-t, in r/r al amyloidosis
-
0:45
difference between quality of life & patient-reported outcomes
-
3:19
how has car-t changed survival outcomes in dlbcl so far?
-
2:58
long-term follow-up: phase ii study of apr-246 aza in tp53-mutated mds & aml
-
0:59
developing lsc-targeting agents in aml: progress and current therapeutic capacity
-
1:52
single-cell and immune sequencing to predict response and resistance to car-t therapy in r/r mm
-
1:21
ensayo andromeda: actualización de resultados de seguridad previos al estudio
-
1:58
updates from the cobalt-lym study: ctx130 in patients with r/r t-cell malignancies
-
1:51
thrombotic and bleeding complications in al amyloidosis
-
2:14
updates on the smart stop trial: the potential for a chemo-free regimen in the frontline for dlbcl